Global and United States Proton Pump Inhibitors Market Insights, Forecast to 2027

Global and United States Proton Pump Inhibitors Market Insights, Forecast to 2027

  • QYResearch
  • September 2021
  • Pharmaceutical
  • 148 pages

Report Description

Proton-pump inhibitors (PPIs) are a group of medications whose main action is a pronounced and long-lasting reduction of stomach acid production.
Proton pump inhibitors (PPIs) reduce the production of acid by blocking the enzyme in the wall of the stomach that produces acid. Acid is necessary for the formation of most ulcers in the esophagus, stomach, and duodenum, and the reduction of acid with PPIs prevents ulcers and allows any ulcers that exist in the esophagus, stomach, and duodenum to heal.
PPIs are among the most widely sold medications in the world. The class of proton-pump inhibitor medications is on the World Health Organization's List of Essential Medicines.
Medically used proton pump inhibitors: Omeprazole, Lansoprazole, Dexlansoprazole, Esomeprazole, Pantoprazole, Rabeprazole.
Global Proton Pump Inhibitors key players include AstraZeneca, Takeda, etc. Global top two manufacturers hold a share over 15%.
North America is the largest market, with a share about 30%, followed by Asia-Pacific, and Europe, having a share about 50 percent.
In terms of product, Esomeprazole is the largest segment, with a share about 30%. And in terms of application, the largest application is Hospital Pharmacy, followed by Retail Pharmacy, etc.

Market Analysis and Insights: Global and United States Proton Pump Inhibitors Market
This report focuses on global and United States Proton Pump Inhibitors market.
In 2020, the global Proton Pump Inhibitors market size was US$ 12810 million and it is expected to reach US$ 10030 million by the end of 2027, with a CAGR of -3.2% during 2021-2027. In United States the Proton Pump Inhibitors market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Proton Pump Inhibitors Scope and Market Size
Proton Pump Inhibitors market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Proton Pump Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Proton Pump Inhibitors market size by players, by Type, and by Distribution Channel, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Dexlansoprazole
Esomeprazole
Lansoprazole
Omeprazole
Pantoprazole
Rabeprazole

Segment by Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Takeda
Pfizer
AstraZeneca
Bayer
Sun Pharma
Teva
Eisai Co.
Mylan
AOSAIKANG Pharma
Luoxin Pharma
LIVZON
Eastchina Pharma

Have query on this report?

Make an Enquiry
1 Study Coverage
1.1 Proton Pump Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global Proton Pump Inhibitors Market Size Growth Rate by Type
1.2.2 Dexlansoprazole
List of Tables
Table 1. Global Proton Pump Inhibitors Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Dexlansoprazole
Table 3. Major Manufacturers of Esomeprazole
Table 4. Major Manufacturers of Lansoprazole
Table 5. Major Manufacturers of Omeprazole

Success Stories

Our Clients